Pharvaris N.V.
PHVS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $817 | $791 | $1,001 |
| - Cash | $329 | $200 | $236 | $281 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | – | $618 | $555 | $721 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$37 | -$40 | -$42 | -$36 |
| % Margin | – | – | – | – |
| Net Income | -$37 | -$45 | -$46 | -$37 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.83 | -0.85 | -0.64 |
| % Growth | 27.7% | 2.4% | -32.8% | – |
| Operating Cash Flow | -$31 | -$30 | -$38 | -$35 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$31 | -$30 | -$39 | -$35 |